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Abstract: The vast number of implications of autophagy in multiple areas of life sciences and
medicine has attracted the interest of numerous scientists that aim to unveil the role of this process
in specific physiological and pathological contexts. Cell cultures are one of the most frequently
used experimental setup for the investigation of autophagy. As a result, it is essential to assess this
highly regulated molecular pathway with efficient and reliable methods. Each method has its own
advantages and disadvantages. Here, we present a review summarizing the most established assays
used to monitor autophagy induction and progression in cell cultures, in order to guide researchers
in the selection of the most optimal solution for their experimental setup and design.
Keywords: autophagy; autophagosome; phagophore; autophagic flux; measurement; assay; method
1. Introduction
Macroautophagy (hereafter simply referred to as autophagy) is an evolutionarily-conserved
intracellular catabolic pathway that allows the turnover of macromolecules and organelles in eukaryotic
cells [1]. This highly dynamic process is characterized by the formation of double-membrane vesicles
called autophagosomes, which sequesters the cargo targeted for destruction before fusing with
lysosomes to deliver their content for degradation. Autophagosome biogenesis starts with the
formation of a membranous cistern known as the phagophore or isolation membrane, which expands
and upon fusion of the two extremities through a fission event, leads to the generation of a
double-membrane vesicle [2]. Complete autophagosomes fuse first with endosomes and, subsequently,
with lysosomes to form amphisomes and autolysosomes, respectively [3]. Autophagy is regulated by
the autophagy-related (ATG) genes and it can be non-selective or selective [4]. Non-selective, bulk
types of autophagy are characterized by heterogeneous cargoes that appear to be randomly sequestered
in the interior of autophagosomes. Selective types of autophagy, in contrast, involve the so-called
autophagy receptors and lead to the exclusive enwrapping of specific structures into autophagomes.
Autophagy is an adaptive response to stress, but it is also involved in a multitude of other
physiological processes, including intracellular quality control, prevention of cellular ageing, cell
differentiation and development, cell death, stemness maintenance, and innate and adaptive
immunity [5]. Consequently, impairments or defects in this pathway lead to severe pathologies,
including specific types of cancer, neurodegeneration, and muscular dystrophies [6]. All these
implications have attracted an enormous interest from the scientific community, as well as the
pharmaceutical industry, in studying the regulation, mechanism, and functions of autophagy. As a
result, it has become of primordial importance to monitor autophagic activity specifically, accurately,
and reliably and, thus, to be able to determine changes of autophagic flux and eventually the blocked
step when this pathway is impaired. The goal of this review is to summarize the established methods
that are most frequently used to assess non-selective, bulk autophagy induction and progression,
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with the purpose of easy access to the detailed practical information that can be found in the literature
(Table 1). The description of assays for the measurement of selective types of autophagy is out of the
scopes of this review and detailed methods can be found elsewhere (e.g., [7–11]).
Table 1. Recent publications providing detailed practical protocols to measure autophagic activity
following the methods presented in this review.
I. Direct Measurement of
Autophagic Activity
Turnover of long-lived proteins [12–14]
LDH sequestration [15,16]
II. Indirect Measurement of
Autophagic Activity
Western blot-based assays (LC3 lipidation, SQSTM1/p62
turnover and post-translational modifications) [17–21]
Fluorescence microscopy-based methods (distribution of




Flow cytometry and imaging flow cytometry [27,28]
2. Materials and Methods
2.1. Methods for the Direct Measurement of Autophagic Activity
2.1.1. The Turnover of Long-Lived Proteins
A direct method to measure autophagic flux is to monitor the degradation of a group of
autophagosomal cargoes, e.g., the long-lived proteins [29,30]. This approach is based on the principle
of radiolabeling long-lived proteins with radioactive amino acids, such as [14C]-leucine, [3H]-leucine,
[14C]-valine, or [35S]-methionine [31], before inducing autophagy and measuring the release of
radioactivity from the labeled proteins, which reflects an activity of this pathway. The involvement
of the proteasome in the degradation of both short-lived and long-lived proteins is important. The
turnover of short-lived proteins by the proteasome can be mostly excluded by discarding the culture
medium after a chase of e.g., 4 h [12]. To rule out the contribution of the proteasome in the degradation
of long-lived proteins from the assay, one option is to use proteasome inhibitors, such as MG132 [32].
The other is to perform the experiments in presence or absence of autophagy inhibitors such as
3-methyl adenine (3-MA), wortmannin, bafilomycin A1, chloroquine, NH4Cl, or leupeptin, to block
lysosomal degradation and determine the non-autophagic protein degradation background [12]
(Table 2). The detailed methodology for the execution of the long-lived protein degradation assay is
explained in detail in the literature [12].
Table 2. Most frequently employed autophagy and lysosomal inhibitors. Refer to [29] for further details.
Compound Class Effect
Bafilomycin A1 Lysosomal inhibitor It increases the lysosomal pH
Chloroquine Lysosomal inhibitor It increases the lysosomal pH
Protease inhibitors (e.g., E-64d,
pepstatin A and leupeptin) Lysosomal inhibitor They inhibit lysosomal proteases
NH4Cl Lysosomal inhibitor It increases the lysosomal pH
Wortmannin Autophagy inhibitor It inhibits autophagosome biogenesis
3-methyladenine Autophagy inhibitor It inhibits autophagosome biogenesis
Long-lived protein degradation by autophagy can also be analyzed quantitatively using
non-radioactive labeling with L-azidohomoalanine (AHA) [13,33]. Cells are conveniently pulse-chase
labeled with this alanine analog as in the standard long-live protein degradation assay, before
performing a click reaction in cells that have been fixed and permeabilized. The click reaction
allows the cross-linking of the azide group of AHA with the alkyne group of an alkyne-tagged
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fluorescent dye. A change in fluorescence intensity in the cells, which can be measured using various
techniques e.g., flow cytometry or immunofluorescent microscopy, indicates a variation in the activity
of autophagy [14]. The major advantage of this technique is that it does not require a special room
since not involving radioactive material. Its disadvantages are, firstly, the limitation in the selection of
culturing media that can be used due to the AHA labeling that requires the absence of methionine
and, secondly, 5% of the proteome only contains the N-terminal methionine and, consequently, is very
poorly labeled with AHA.
Independently of the methods used to measure the turnover of long-lived proteins, our suggestion
is to first employ more simple techniques to establish the experimental conditions and/or determine
whether there is a change in the autophagic flux, before proceeding with this measurement.
2.1.2. LDH Sequestration
Another method to directly assess the autophagic activity is to measure the sequestration of
endogenous lactate dehydrogenase (LDH). LDH is a ubiquitous and abundant cytosolic enzyme that
is non-selectively enwrapped into autophagosomes, and its sequestration can thereby be used as a
measurement of autophagy. In particular, the measurement of the LDH pool in the cytosol versus
the one that is sequestered allows a quantitative analysis of the autophagic flux. It is important to
include lysosomal inhibitors in the samples to avoid the degradation of part of the sequestered LDH
in lysosomes. After separating the sequestered and the non-sequestered fractions by centrifugation,
the LDH amounts in the two fractions can be determined by either the enzymatic measurement of
NADH decline or by LDH levels by western blot [16]. This technique was initially developed by Seglen
and colleagues for isolated rat hepatocytes [34]. Recently, this assay has been adapted to mammalian
cell cultures and validated by showing the accumulation of sequestered LDH upon treatment with
various autophagy activators and lysosomal inhibitors such as vinblastine, chloroquine, rapamycin,
and leupeptin/pepstatin (Table 2) [16,35].
Detailed practical reviews on the LDH sequestration assay have recently been published [15,16]
(Table 1). As for the long-lived protein turnover assay, it is advised to use a more straightforward
method to set the experimental conditions and/or establish whether there is a change in the autophagic
flux before applying this method.
2.2. Methods for the Indirect Measurement of Autophagic Activity
2.2.1. Western Blot-Based Assays
LC3 Lipidation
Members of the microtubule-associated protein 1 light chain 3 (MAP1-LC3) protein family,
the mammalian homologues of yeast Atg8, play an important role in autophagosome biogenesis
and closure [36,37]. LC3 proteins are classified into the LC3 and GABARAP subfamilies, and the
mostly-studied isoform is LC3B [38]. Members of the ATG4 cysteine protease family cleave the
C-terminal amino acids of newly-synthesized LC3 proteins to expose a glycine residue, which can
subsequently be conjugated to phosphatidylethanolamine (PE) upon autophagy induction, leading to
their association to the internal and external surface of the expanding phagophores [39]. While the LC3
population on the surface of autophagosomes is released upon completion of these vesicles by ATG4
protease cleavage, the internal pool of LC3 is delivered and degraded in the lysosome together with the
cargo. The lipidated form of LC3, also referred to as LC3-II, has an apparent molecular weight of 14–16
kDa on SDS-PAGE gels while non-lipidated LC3-I migrates around 16–18 kDa [36]. This difference
in mobility, which is detectable by western blot, is frequently used as an indirect way to determine
autophagosome formation through the measurement of LC3-II levels. It must be noted that the ratio
between LC3-I and LC3-II can vary depending on both the examined cell type and the employed
antibody because this latter could recognize preferentially one of the two forms of LC3.
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Analysis in the difference of the LC3-I/LC3-II ratio, however, will remain inconclusive without
inhibition of the lysosomal degradative activity. Low levels of LC3-II could be due to an inhibition
of autophagy or a high autophagic flux. Conversely, high levels of LC3-II could be caused by the
impairment in autophagosome fusion with lysosomes or cargo degradation, or induction of autophagy.
Pharmacologically blocking the proteolytic activity of lysosomes prevents the turnover of the LC3-II
pool present in the autophagomes allowing the quantification of the total levels of LC3-II generated
over the period of the experiment. As a result, the combinatorial evaluation of the same sample treated
or not with a compound blocking lysosomal degradation, permits to determine whether there has
been an induction or inhibition of the autophagic flux [29]. One of the most frequently employed
drugs is Bafilomycin A1, an inhibitor of the lysosomal V-ATPase. Bafilomycin A1 provokes an increase
in the lysosomal pH that blocks lysosomal degradation and, in specific cell types, also the fusion of
autophagosomes with lysosomes. Other compounds such as protease inhibitors, e.g., a cocktail of
pepstatin A, leupeptin and E-64d, or other pH modulators, such as chloroquine or NH4Cl, can also be
employed (Table 2) [40,41].
In conclusion, the analysis of LC3 lipidation by Western blot is the go-to method to assess changes
in autophagy in most cell lines. It is advised to perform this analysis in presence and absence of a
lysosomal inhibitor. When possible, starving the cells for nutrients could provide a positive control,
while the depletion of one of the ATG proteins could serve as the negative control. It is also important
that when quantifying LC3-II, the LC3-II/loading control protein ratio is calculated rather than the
LC3-II/LC3-I ratio since the latter might not correctly reflect changes in autophagy. One important
note is that while LC3 was previously believed to be essential for autophagy, recent reports have shown
that both starvation-induced bulk autophagy and PINK1/Parkin-dependent mitophagy do not require
the members of the LC3 protein family [37,42]. Moreover, the autophagic flux can be maintained
at high levels even at time periods when there was no LC3 flux under starvation conditions [42].
Altogether, these studies indicate that, under specific circumstances, LC3 may have a very limited
value as a general marker protein for autophagy.
SQSTM1/p62 Turnover
The turnover of SQSTM1/p62 is an alternative method widely used to monitor autophagic
activity by Western blot. This protein is an autophagy receptor for various ubiquitinated
cargoes [43]. SQSTM1/p62 binds specific cargo proteins through an ubiquitin-binding domain and
simultaneously anchors them onto the LC3 pool present on the autophagosome interior, through an
LC3 interacting region (LIR). These interactions allow the sequestration of targeted cargoes into nascent
autophagosomes and subsequent lysosomal degradation. SQSTM1/p62 turnover can serve as a marker
for autophagic activity in normal growing conditions in cells where this transport route works at basal
level [44]. An induction of autophagy, however, increases the degradation of SQSTM1/p62 while a
decrease or block of this pathway causes its accumulation. Identically, as for the LC3 Western blot
analysis, the measurement of the autophagic flux using SQSTM1/p62 requires that the experiments
are performed in the absence and presence of lysosomal inhibitors.
An important aspect to consider when analyzing SQSTM1/p62 turnover is that the expression
of this protein is transcriptionally regulated. It has been reported that under certain conditions,
such as amino acid starvation, some cell lines have increased SQSTM1/p62 expression and,
although autophagy is stimulated, the steady-state levels of SQSTM1/p62 remain unchanged because
degradation is compensated by the de novo synthesis [18]. As a result, it is not possible to use the
assessment of SQSTM1/p62 turnover by Western blot to measure the autophagic flux in all tissues.
A way to employ this method also in cell types, where the steady-state levels of SQSTM1/p62 appear to
vary upon autophagy induction, is to add cycloheximide in order to block the de novo synthesis or to
perform a pulse-chase radiolabeling experiments followed by SQSTM1/p62 immuno-precipitation [18].
Several methodological reviews describing the more practical aspect of these Western blot analyses
can be found in the literature [17–19] (Table 1). Overall, however, it is advised to analyze SQSTM1/p62
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turnover in combination with LC3 lipidation levels for a firmer establishment of changes in the
autophagic flux.
Post-Translational Modifications during Autophagy
Post-translational modifications (PTM) have a key role in the regulation of autophagy in both
basal and stress-induced conditions, and several of them are regulated by the nutrient and energy
state of the cell [45]. The most widely characterized PTM are amino acid phosphorylations by protein
kinases, which are antagonized by the action of protein phosphatases [46].
The serine (Ser)/threonine kinase ULK1 and ULK2 have a redundant role, and they are both part
of a complex that also includes ATG13, FIP200, and ATG101. In the presence of nutrients, this complex
is associated with an active mTORC1 complex, which phosphorylates ULK1 at Ser638 and Ser758,
ATG13 at Ser389, and AMBRA1 at Ser52 [45], and thereby inhibits the kinase activity of ULK1 and ULK2
and, ultimately, autophagy. Another inhibitory phosphorylation of ULK1 is maintained by the AKT
kinase, which responds to insulin signaling, at Ser774 [47]. Upon nutrient depletion and consequent
inhibition of mTORC1, dephosphorylation of ULK1 is followed by both autophosphorylation at Ser180
and ULK1-mediated phosphorylation of ATG13 at Ser318 and Ser203, FIP200 at Ser943, Ser986, and
Ser1323, and AMBRA1 at Ser465 and Ser635 [48,49]. Another stimulus for autophagy activation is the
decrease in the cellular energy levels, which are sensed by the AMPK kinase, which phosphorylates
ULK1 at Ser317 and Ser777 triggering its activity [50]. AMPK also activates TSC2, which inhibits
mTORC1 and thereby blocks the inhibitory phosphorylation of ULK1 [29]. All these PTM can be
monitored by Western blot using phospho-specific antibodies, and their examination, singularly or
in combination, indicates whether autophagy is induced or inhibited. While preparing samples, the
presence of phosphatase inhibitors is essential to be able to detect these PTM. The activity of mTORC1
pathway and AMPK can also be used as an indirect method to examine autophagic activity by western
blot, through the analysis of the phosphorylation status of specific downstream substrates of these
kinases, such as 4EBP-1, RPS6KB/p70S6, or RPS6/S6 [51,52].
Another important PTM that can be monitored by Western blot are acetylation/deacetylation.
This type of modification is often dictated by the availability of nutrients since the levels of acetyl
co-enzyme A (AcCoA) drop when those become scarce. Deacetylation of specific proteins can,
thus, be observed under conditions triggering autophagy such as caloric restriction [53]. General
deacetylations can be quantified directly by either Western blot or immunofluorescence, with antibodies
recognizing acetylated lysine residues [54]. Components of the ATG machinery can be directly
acetylated/deacetylated, e.g., LC3 deacetylation, or their expression can get modulated through the
deacetylation of transcription factors such as FOXO that are required for ATG gene expression [55].
The use of acetylation-specific antibodies but in this case on specific immunoprecipitated proteins, can
provide an indication about autophagy progression.
Detailed reviews on how to analyze deacetylayion and other PTM when monitoring autophagy
are available [20,21] (Table 1). This approach, however, must not be the primary methods of choice
to monitor variations in the autophagic flux since quite indirect. Detecting specific PTM might be
valuable to point to the signaling pathway regulating the changes of autophagy that are being studied.
2.2.2. Fluorescence Microscopy-Based Methods
Fluorescent microscopy allows a qualitative and quantitative analysis of the different step
of autophagy through the examination of the subcellular distribution of either endogenous
autophagosomal protein markers by immunofluorescence or ectopically-expressed fusion proteins by
either immunofluorescence or live-cell imaging. When relying on the transfection of reporter proteins,
the generation of stably-transfected cell lines permits obtaining a homogeneous protein expression
with the advantage of decreasing the variability of signal intensity and size within a cell population.
Consequently, stable transfected cell lines are especially suitable for automated microscopy-based
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measurements as well as a live-cell imaging [29]. The use of autophagy and lysosomal inhibitors
allows to optimally control these experimental approaches as well.
Dyes labeling autophagosomal compartments such as Cyto-ID® Green dye, can also be an option
to visualize autophagic activity microscopically, especially in living cells or in cells that are difficult to
be transfected. The major limitation of these dyes is their partial specificity but with the appropriate
controls, they can be reliably used in high-content screens or difficult experimental settings [56,57].
Distribution of Autophagosomal Protein Markers
The members of the LC3 protein family are cytosolic and they change from a homogeneous
cytoplasmic distribution into puncta upon autophagy induction as they become conjugated with
autophagosomal membranes [36]. This difference in localization allows the quantification of
autophagosomes within each individual cell. Since autophagosome fusion with lysosomes will
ultimately lead to LC3 protein degradation, lysosomal inhibitors should be included in the
experimental setup to determine the total number of autophagosomes that are formed over the time of
the experiment. It must be noted that the number of LC3-positive puncta per cells in normal conditions
can differ greatly, which may reflect different levels in basal autophagy [58]. Consequently, stimulation
of autophagy does not always lead to a significant change in the number of LC3-positive puncta
per cell.
Although all members of the ATG machinery localize to autophagosomes, the most studied
one is LC3B because it is ubiquitously expressed and good antibodies, constructs, and stable
cell lines are available as it was one of the first members of the LC3 protein family to be
characterized. Since its expression levels can vary considerably from tissue to tissue, GFP-LC3
has been frequently used to surmount this limitation [36,59]. The sensitivity in GFP-LC3 detection,
however, is variable from one cell type to another in culture conditions because of GFP quenching in
low pH [29]. Therefore, alternative fluorophores such as mCherry, mRFP, and mTAgRFP, or protein
tags detectable by immunofluorescence, are more ideal to probe LC3 [22]. Another important point
of caution is that overexpressed GFP-LC3 can form puncta corresponding to aggregates rather than
autophagosomes [60].
SQSTM1/p62 can also be used to monitor autophagy induction and flux. This autophagy receptor
forms aggregates upon autophagy stimulation, which are delivered and degraded in lysosomes [61].
SQSTM1/p62 appears as discrete puncta when analyzed by immunofluorescence. Endogenous
SQSTM1/p62 can be detected practically in all tissues because it is expressed ubiquitously. Although
formation and accumulation of SQSTM1/p62 puncta can reveal an induction and a defect in autophagy,
respectively, the additional use of lysosomal inhibitors allows estimating the autophagic flux. Several
low and high throughput, fluorescent microscopy-based screens have exploited the SQSTM1/p62
puncta formation to identify autophagy modulators (e.g., [62–66]).
The analysis of the subcellular distribution of early autophagosomal protein markers such
as double FYVE-containing protein 1 (DFCP1), WD-repeat domain phosphoinositide-interacting-1
(WIPI1) and WIPI2 also permits to specifically follow the induction of autophagosome biogenesis.
These proteins are not abundant and consequently their localization is almost always examined
by transfecting cells with plasmids expressing fusion proteins. DFCP1 is associated to the ER
and through the binding of the PtdIns3P pool present on phagophores, relocalizes to punctuate
structures corresponding to forming autophagomes upon autophagy stimulation [67]. This subcellular
redistribution can be easily monitored and it is an indicator of autophagy induction. WIPI1 and WIPI2,
in contrast, are cytoplasmic but they also associated to autophagosomal precursor structures through
PtdIns3P binding [68]. Here as well, this easily detectable change in localization allows establishing
whether autophagy has been triggered. It is important to note, however, that the autophagic flux
and the effects of the autophagy stimuli are highly variable between cell types. Therefore, these
fluorescent microscopy-based methods should be approached cautiously since some events maybe
underrepresented depending on the time point of the experiment.
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The localization of other ATG proteins, including ATG9A, ATG13, FIP200, ULK1, ATG16, and
SYNTAXIN17, or organelle protein markers, such as lysosomal LAMP1, might also be employed
to provide evidence for autophagic activity and crosstalk with other cellular pathways [29,69].
Examination of one or more specific marker proteins allows monitoring a specific stage of autophagy
or when a defect is detected, determine the step that is blocked. Nonetheless, the advice is to use the
fluorescent-base assays in combination with other methods to measure autophagy, since some of the
mentioned marker proteins are also involved in other pathways.
Molecular Tandem Probes
A very important development in the field of autophagy was the generation of fluorescent-tagged
probes to visually monitor the autophagy flux. The most frequently used one is LC3 fused with either
mRFP-GFP or mCherry-GFP [22]. This probe generates a yellow signal when LC3 is associated to
cytoplasmic autophagosomal precursor structures and vesicles. Upon fusion of autophagosomes with
lysosomes, the low pH of these organelles quenches the GFP signal, which results in only the mRFP or
mCherry fluorescent signal being detectable in the autolysosomes. The quantification of the yellow
and red puncta consequently permits a quantitative measurement of both the induction and flux of
autophagy [22].
Recently, a new fluorescent probe, i.e., GFP-LC3-RFP-LC3∆G, has been developed to monitor the
autophagic flux [23]. This probe is cleaved by endogenous ATG4 proteases resulting in the formation
of two fusion proteins, GFP-LC3 and RFP-LC3∆G. GFP-LC3 is partially degraded by autophagy while
RFP-LC3∆G, a mutant form of LC3 that cannot be conjugated to PE, remains free in the cytosol as
it is not a substrate of autophagosomes. The GFP/RFP signal ratio thus measures the autophagic
activity [23].
Another recently-developed method to monitor the autophagic flux is the one based on the
renilla luciferase-LC3 (RLuc-LC3) reporter construct [70]. Although not a tandem probe, degradation
of RLuc-LC3, and the consequent decrease in the luminescence signal, allows monitoring of the
autophagic flux. It is crucial to include the non-lipidable RLuc-LC3G120A construct in the experiments
as a negative control.
2.2.3. Electron Microscopy
Transmission electron microscopy (EM) has a central position in the field of autophagy as
autophagosomes were first observed and described as large double-membrane vesicles sequestering
cytoplasmic components by Christian de Duve in 1950s using this technique [71]. Opposite to the rest of
the other methods commonly used to monitor autophagy, EM allows to directly count autophagosomes
and autolysosomes [72,73]. The sequestration of specific substrates by autophagosomes, e.g., organelles
or bacteria, can be distinctly analyzed and also quantified during the dynamic process of phagophore
elongation and completion, and if cells are incubated with lysosomal inhibitors, the autophagosomal
cargo can be promptly detected in the interior of lysosomes [24]. The correctness of the morphological
observations depend highly on the procedure applied for sample preparation as for example,
visualization of the double membrane of autophagosomes can exclusively be detected when cells
are fixed using determined methods [74–76]. Various EM techniques have been applied to follow
autophagy at the ultrastructural level, including transmission EM, immuno-EM, electron tomography,
cryo-soft X-ray microscopy, and focused ion beam scanning electron microscopy (FIB-SEM) [77,78].
Detailed reviews describing the application of these techniques for the study of autophagy are
available [9,10,26,36].
In most of the situations, however, an analysis of cells by conventional transmission EM
in presence and absence of lysosomal inhibitors, is sufficient to determine whether there is an
enhancement of the autophagic flux. Upon autophagy induction, the number of degradative
compartments increases and as a result the quantification of the number of autolysosomes, lysosomes
and amphisomes per cell section, provides a simple morphological readout [29]. Since it is very difficult
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to distinguish between autolysosomes, lysosomes, and amphisomes, even for an expert eye [74], it is
much simpler to classify all these organelles together, as degradative compartments. One should keep
in mind that in specific situations, the number of degradative organelles could change independently
of an induction of autophagy. Although it is also possible to count autophagosomes, their transient
appearance makes it very difficult to detect them when the fusion of autophagosomes and lysosomes
are not pharmacologically blocked.
Ultrastructural approaches are time-consuming and, therefore, it is advised to use them to obtain
firm conclusions on key experiments. It must be noted that the morphology of the cell is not well
preserved under certain conditions and that the volume of the cytoplasm is reduced in cell types, such
as stem cells, making the detection of autophagosomes and degradative compartments difficult.
2.2.4. Flow Cytometry and Imaging Flow Cytometry
Both flow cytometry and imaging flow cytometry can be employed as a high-content analysis
method to measure autophagic flux in living cells, especially if those do not adhere to surface, e.g., blood
cells. While flow cytometry exclusively acquires an intensity reading for the entire signal in the cell,
imaging flow cytometry, which is a combination of flow cytometry and microscopy, collects fluorescent
images of the cells and as a result the location of the signal within the cell can be visualized and
measured. The type of information acquired with these two approaches is consequently very different.
In cells expressing GFP-tagged LC3 or RLuc-LC3, induction of autophagy will lead to the
transport of this protein into the lysosome, where GFP is quenched by protons and/or degraded.
Therefore, a decrease in the total fluorescence or luminescence signal per cell, will reflect an autophagic
activity [70,79–83]. The use of cells expressing tandem mRFP/mCherry-GFP-LC3 allows to more
directly assess the autophagic flux because as explained above, permits the differentiation between
autophagosomes and autolysosomes. To have a better signal to noise read-out, however, cell
permeabilization with saponin permits the release of the cytosolic pool of LC3 leaving, intracellularly,
the portion of this protein that is associated with autophagosomes [80]. Fixation and permeabilization
of the cells also allows the staining and measurements of endogenous LC3, and an analysis of
the autophagic flux can be obtained by treating, or not, cells with lysosomal inhibitors for the
reason explained throughout this review [84]. Fluorescently-tagged autophagy substrates such
as GFP-SQSTM1/p62 or GFP-NBR1, can also be used as protein markers for autophagic flux
measurements by flow cytometry and imaging flow cytometry as their degradation provokes a
significant decrease in the fluorescent signal [85,86].
The use of flow cytometry and imaging flow cytometry to measure the autophagic flux, however, is
not optimal for all cell types. Cells in suspensions or with low adherence are more ideal as scrapings of
adherent cells could have indirect stimulatory effects on autophagy, creating artifacts [29]. Nevertheless,
these techniques can be very convenient for high-content screens or to differentiate the autophagic
flux between different cell populations by combining the autophagy marker proteins with other
ones [65,66,82]. Detailed reviews on the practical aspects of the flow cytometry- and imaging flow
cytometry-based methods to measure autophagy are available [27,28] (Table 1).
3. Conclusions
With the exponentially-increasing medical interest for autophagy, there has been a great focus
in the development and optimization of various techniques to measure autophagy progression,
in particular for experiments realized with mammalian cells in culture. In addition to the
methods described above (Table 1), there are multiple other approaches to assess autophagy,
as well as non-canonical types of autophagy or chaperone-mediated autophagy. Those include
immuno-histochemistry or degradative compartment isolation through subcellular fractionation.
Upon adaptation, the methods described in this review are also applicable for the measurement of
autophagy induction and flux in newly-emerging in vitro systems, such as 3D mammalian cell cultures
and organoids [87].
Cells 2017, 6, 20 9 of 13
It is important to note that most of the assays used to monitor autophagy involve indirect
methods and/or marker proteins that often are also part of other cellular pathways [88–90]. It is,
therefore, critical and necessary that more experimental approaches are used in parallel to obtain a
firm conclusion whether there is a change in the autophagic flux. We hope that this review provides
a helpful handbook to guide researchers in selecting a few of them for their studies in mammalian
cell cultures.
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